Fingerprint
Dive into the research topics of 'Phase II studies of polymer-doxorubicin (PK1, FCE28068) in the treatment of breast, lung and colorectal cancer.'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase II studies of polymer-doxorubicin (PK1, FCE28068) in the treatment of breast, lung and colorectal cancer.
LW Seymour, DR Ferry, DJ Kerr, Daniel Rea, M Whitlock, R Poyner, C Boivin, S Hesslewood, C Twelves, R Blackie, A Schatzlein, D Jodrell, D Bissett, H Calvert, M Lind, A Robbins, S Burtles, R Duncan, J Cassidy
Research output: Contribution to journal › Article › peer-review
218
Citations
(Scopus)